BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37957863)

  • 1. Curcuminoids Modulated the IL-6/JAK/STAT3 Signaling Pathway in LoVo and HT-29 Colorectal Cancer Cells.
    Li Q; Ding Y; Ou Y; Li M; Jithavech P; Buranasudja V; Sritularak B; Xu Y; Rojsitthisak P; Han J
    Curr Pharm Des; 2023; 29(36):2867-2876. PubMed ID: 37957863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
    Wang SW; Sun YM
    Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC.
    Wang S; Zhang W
    Tumour Biol; 2016 May; 37(5):6561-9. PubMed ID: 26638167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway.
    Khan AQ; Ahmed EI; Elareer N; Fathima H; Prabhu KS; Siveen KS; Kulinski M; Azizi F; Dermime S; Ahmad A; Steinhoff M; Uddin S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway.
    Ham IH; Wang L; Lee D; Woo J; Kim TH; Jeong HY; Oh HJ; Choi KS; Kim TM; Hur H
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35621145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Rhizoma paridis total saponins on apoptosis of colorectal cancer cells and imbalance of the JAK/STAT3 molecular pathway induced by IL-6 suppression.
    Teng WJ; Chen P; Zhu FY; Di K; Zhou C; Zhuang J; Cao XJ; Yang J; Deng LJ; Sun CG
    Genet Mol Res; 2015 May; 14(2):5793-803. PubMed ID: 26125778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway.
    Xue J; Liao L; Yin F; Kuang H; Zhou X; Wang Y
    Cancer Biomark; 2018; 21(4):849-858. PubMed ID: 29439310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of Shengjiang Powder on experimental autoimmune encephalomyelitis mice through IL-6/JAK2/STAT3 signaling pathway:based on HPLC].
    Lyu BJ; Zheng ZQ; Zheng KN; Wu LL; Xu HY; Tong PZ; Wu WP; Wu ZB; Zhao YQ
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3361-3371. PubMed ID: 35851130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway.
    Yang CL; Liu YY; Ma YG; Xue YX; Liu DG; Ren Y; Liu XB; Li Y; Li Z
    PLoS One; 2012; 7(5):e37960. PubMed ID: 22662257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.
    Xue X; Jungles K; Onder G; Samhoun J; Győrffy B; Hardiman KM
    Oncotarget; 2016 Mar; 7(10):11567-79. PubMed ID: 26871465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK/STAT3 signaling pathway.
    Du L; Chang H; Xu W; Wei Y; Wang Y; Yin L; Zhang X
    Life Sci; 2020 Oct; 258():118217. PubMed ID: 32768575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
    Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
    Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.
    Wang SW; Hu J; Guo QH; Zhao Y; Cheng JJ; Zhang DS; Fei Q; Li J; Sun YM
    Oncol Rep; 2014 Nov; 32(5):1991-8. PubMed ID: 25216185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of moxibustion combined with acupoint catgut embedding on IL-6/JAK/STAT3 signaling pathway in colonic mucosa of ulcerative colitis rats].
    Wang YJ; Yu QH; Lu YW; Zhang Q; Hou XR; Zhou YL; Li LH
    Zhen Ci Yan Jiu; 2022 Jun; 47(6):525-30. PubMed ID: 35764520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells.
    Wei X; Wang G; Li W; Hu X; Huang Q; Xu K; Lou W; Wu J; Liang C; Lou Q; Qian C; Liu L
    Oncol Rep; 2014 Jan; 31(1):335-41. PubMed ID: 24253664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma.
    Gordziel C; Bratsch J; Moriggl R; Knösel T; Friedrich K
    Br J Cancer; 2013 Jul; 109(1):138-46. PubMed ID: 23756862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling.
    Fiebelkow J; Guendel A; Guendel B; Mehwald N; Jetka T; Komorowski M; Waldherr S; Schaper F; Dittrich A
    Cell Commun Signal; 2021 Sep; 19(1):94. PubMed ID: 34530865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation.
    Chen Y; Sun L; Li D; Yin X; Shang G; Diao T; Shi L
    Turk J Gastroenterol; 2022 Sep; 33(9):731-742. PubMed ID: 35946886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
    Pennel KAF; Hatthakarnkul P; Wood CS; Lian GY; Al-Badran SSF; Quinn JA; Legrini A; Inthagard J; Alexander PG; van Wyk H; Kurniawan A; Hashmi U; Gillespie MA; Mills M; Ammar A; Hay J; Andersen D; Nixon C; Rebus S; Chang DK; Kelly C; Harkin A; Graham J; Church D; Tomlinson I; Saunders M; Iveson T; Lannagan TRM; Jackstadt R; Maka N; Horgan PG; Roxburgh CSD; Sansom OJ; McMillan DC; Steele CW; Jamieson NB; Park JH; Roseweir AK; Edwards J
    J Exp Clin Cancer Res; 2024 Mar; 43(1):64. PubMed ID: 38424636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.